Ok. But you continue to cut and paste (3 or 4 times now) the same excerpt from an AVZ announcement to try and get your point across. Maybe no one's listening?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%